Clinical Trials
15 trialsNCT01362803 2026-05-22
AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Phase 1/2 Active not recruiting
NCT07034950 2025-09-11
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
The First Affiliated Hospital of Xiamen University
Phase 1/2 Active not recruiting
NCT04310410 2024-02-07
PRE-FURTHER
UMC Utrecht
Phase 1/2 Completed
NCT03146806 2021-09-09
Intranasal (NAS) Ketamine for Cancer Pain
Emory University
Phase 1/2 Completed
NCT00374751 2019-08-26
Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
New York Presbyterian Brooklyn Methodist Hospital
Phase 1/2 Completed
NCT03016364 2019-01-23
Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT00482378 2018-08-14
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Mayo Clinic
Phase 1/2 Completed
NCT00769990 2017-12-13
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
Masonic Cancer Center, University of Minnesota
Phase 1/2 Withdrawn
NCT01895790 2017-03-06
Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer
Johns Hopkins University
Phase 1/2 Withdrawn
NCT00588640 2016-08-10
Study of D-Methadone in Patients With Chronic Pain
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00503984 2016-06-09
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
University of Miami
Phase 1/2 Terminated
NCT01248611 2014-05-12
NFCP1-2010
St. Olavs Hospital
Phase 1/2 Completed
NCT00060138 2013-05-15
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Chugai Pharmaceutical
Phase 1/2 Completed
NCT00637364 2009-01-13
HIFU Pancreas
CMED HIFU Development Corporation
Phase 1/2 Suspended
NCT00188383 2006-03-14
Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy
University Health Network, Toronto
Phase 1/2 Unknown